Empagliflozin
Overview
Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used in the treatment of type 2 diabetes. It helps lower blood sugar levels by preventing glucose reabsorption in the kidneys, promoting its excretion.
API suppliers (42)
Suppliers of Empagliflozin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 35 of 42 suppliers.
18 of 42 hold a GMP certificate on record in the EU or UK registers
- Zydus Lifesciences LimitedIndia2 active DMF GMP on record
- BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTDChina1 active DMF
- MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
- LUPIN MANUFACTURING SOLUTIONS LTD1 active DMF
- HONOUR LAB LTDIndia1 active DMF GMP on record
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
- Alembic Pharmaceuticals LimitedIndia1 active DMF GMP on record
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
- Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- Macleods Pharmaceuticals Ltd.India1 active DMF GMP on record
- TAPI NL BVNetherlands1 active DMF
- Cipla USA, Inc.USA1 active DMF
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
- Laurus Labs LimitedIndia1 active DMF GMP on record
- FUXIN LONG RUI PHARMACEUTICAL CO LTD1 active DMF
- ZAKLADY FARMACEUTYCZNE POLPHARMA SA1 active DMF
- Piramal Pharma LimitedIndia1 active DMF GMP on record
- MOREPEN LABORATORIES LTDIndia1 active DMF GMP on record
- METROCHEM API PRIVATE LTDIndia1 active DMF
- EMNAR PHARMA PRIVATE LTDIndia1 active DMF
- COHANCE LIFESCIENCES LTDIndia1 active DMF GMP on record
- AMI LIFESCIENCES PRIVATE LTDIndia1 active DMF GMP on record
- Jiangxi Synergy Pharmaceutical Co., LtdChina1 active DMF
- Zhejiang Huayi Pharmaceutical Co., Ltd.China1 active DMF
- CHEMO SMS ENTERPRISE SLSpain1 active DMF
Showing 25 of 42 suppliers — see the full list in the app.
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Empagliflozin expires 11 Dec 2034 and exclusivity 20 Dec 2026. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Empagliflozin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.